Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$15.36 - $27.51 $1.24 Million - $2.22 Million
80,635 New
80,635 $2 Million
Q4 2021

Feb 11, 2022

SELL
$18.38 - $40.5 $4.81 Million - $10.6 Million
-261,536 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$13.18 - $19.83 $1.46 Million - $2.2 Million
110,901 Added 73.62%
261,536 $4.47 Million
Q2 2021

Aug 10, 2021

BUY
$9.59 - $50.88 $1.44 Million - $7.66 Million
150,635 New
150,635 $2.02 Million
Q4 2020

Feb 10, 2021

SELL
$47.25 - $65.16 $223,823 - $308,662
-4,737 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$46.35 - $61.69 $219,559 - $292,225
4,737 New
4,737 $260,000
Q4 2019

Feb 10, 2020

SELL
$6.81 - $39.55 $97,989 - $569,084
-14,389 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$6.47 - $8.96 $247,509 - $342,764
-38,255 Reduced 72.67%
14,389 $98,000
Q2 2019

Aug 09, 2019

BUY
$8.31 - $14.85 $354,546 - $633,575
42,665 Added 427.55%
52,644 $490,000
Q1 2019

May 13, 2019

SELL
$10.01 - $13.89 $31,891 - $44,253
-3,186 Reduced 24.2%
9,979 $139,000
Q4 2018

Feb 06, 2019

BUY
$9.15 - $12.26 $120,459 - $161,402
13,165 New
13,165 $144,000
Q2 2018

Aug 14, 2018

SELL
$10.62 - $13.98 $42,065 - $55,374
-3,961 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$5.9 - $14.99 $23,369 - $59,375
3,961 New
3,961 $54,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.